CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Name: CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
License: Public Domain

Regeneron Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

squamous cell carcinoma of head and neck

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 127583
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.